← Back to Search

Tobacco Quitline for Quitting Smoking (SFH Trial)

N/A
Waitlist Available
Led By Matthew Kreuter, Ph.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month follow-up
Awards & highlights

SFH Trial Summary

This trial will test whether expanded services to help low-income smokers quit will be more effective than the current standard practice.

Eligible Conditions
  • Quitting Smoking
  • Smoking
  • Health Inequalities

SFH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
7day point prevalence for smoking
Secondary outcome measures
Proportion of participants who accept the tobacco quitline program

SFH Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Tobacco Quitline plus Smoke Free HomesExperimental Treatment2 Interventions
Smokers in this study group will be offered their state Tobacco Quitline programs, but if they decline, they will be offered a Smoke Free Homes intervention
Group II: Tobacco Quitline onlyActive Control1 Intervention
Smokers in this study group will be offered their state Tobacco Quitline programs
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tobacco Quitline
2020
N/A
~1990
Smoke Free Home
2020
N/A
~1990

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,931,685 Total Patients Enrolled
2 Trials studying Quitting Smoking
13,098 Patients Enrolled for Quitting Smoking
Washington University School of MedicineLead Sponsor
1,931 Previous Clinical Trials
2,297,727 Total Patients Enrolled
Matthew Kreuter, Ph.D.Principal InvestigatorWashington University School of Medicine

Media Library

Tobacco Quitline Clinical Trial Eligibility Overview. Trial Name: NCT04311983 — N/A
Quitting Smoking Research Study Groups: Tobacco Quitline only, Tobacco Quitline plus Smoke Free Homes
Quitting Smoking Clinical Trial 2023: Tobacco Quitline Highlights & Side Effects. Trial Name: NCT04311983 — N/A
Tobacco Quitline 2023 Treatment Timeline for Medical Study. Trial Name: NCT04311983 — N/A
Quitting Smoking Patient Testimony for trial: Trial Name: NCT04311983 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this investigation have any additional capacity for participants?

"Affirmative. Information on clinicaltrials.gov discloses that this investigation is opening its arms to volunteers. This research project, which was initially posted online on March 31st 2020, is expecting 1,980 individuals at a single site."

Answered by AI

How many subjects are currently involved in this clinical research?

"Affirmative. Clinicaltrials.gov has detailed information on this ongoing clinical trial, which first launched on March 31st 2020 and was last updated on May 11th 2022. The investigators are looking to involve 1 medical centre in enlisting a total of 1980 patients for the study."

Answered by AI

Who else is applying?

What state do they live in?
Missouri
Kansas
What site did they apply to?
Washington University School of Medicine
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Because I'm traveling from NY to Missouri to see family and I need to make money and I'd like to quit smoking cigarettes.. I've been smoking since I was 11 and I'm 37 now.
PatientReceived 1 prior treatment
~396 spots leftby Apr 2025